Bertesi M, Tavernari L, Neroni A, Papa E, Rontauroli S, Bianchi E, Mirabile M, Norfo R, Parenti S, Tombari C, Carretta C, Malerba M, Fabbiani L, Guglielmelli P, Losi L, Tagliafico E, Vannucchi AM, Manfredini R. P007 | Pre-clinical efficacy of a novel combined pharmacological approach targeting JAK and ERK in a myelofibrosis mouse model: M. Bertesi1|3, L. Tavernari1|2, A. Neroni1|3, E. Papa1|3, S. Rontauroli1|2, E. Bianchi1|3, M. Mirabile1|2, R. Norfo1|2, S. Parenti1|2, C. Tombari1|2, C. Carretta1|2, M. Malerba1|3, L. Fabbiani4, P. Guglielmelli5|6, L. Losi4, E. Tagliafico7|8, A. M. Vannucchi5|6, R. Manfredini1|2 | 1Interdepartmental Centre for Stem Cells and Regenerative Medicine, University of Modena and Reggio Emilia; 2Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia; 3Department of Life Sciences, University of Modena and Reggio Emilia; 4Pathology Unit , Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia; 5CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi; 6Department of Experimental and Clinical Medicine, University of Florence; 7Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia; 8Department of Laboratory Medicine, Diagnostic Hematology and Clinical Genomics Unit, Modena University Hospital. Haematologica 2026; 111(s1); https://doi.org/10.3324/haematol.2026.s1.80.